相似文献
1
Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART).
Clin Immunol. 2008 Sep;128(3):349-57. doi: 10.1016/j.clim.2008.04.008. Epub 2008 Jul 7.
2
HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment.
AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):21-9. doi: 10.1089/08892220360473934.
3
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
AIDS. 2009 Sep 24;23(15):1955-64. doi: 10.1097/QAD.0b013e32832ff1ff.
4
In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors.
Immunology. 2001 Sep;104(1):19-27. doi: 10.1046/j.1365-2567.2001.01282.x.
5
The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy.
AIDS. 2013 Jun 19;27(10):1557-62. doi: 10.1097/QAD.0b013e3283611888.
6
Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.
J Infect Dis. 2004 Apr 15;189(8):1482-6. doi: 10.1086/382961. Epub 2004 Mar 30.
7
T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.
Clin Exp Immunol. 2001 Apr;124(1):21-31. doi: 10.1046/j.1365-2249.2001.01502.x.
8
Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count.
PLoS One. 2015 Jul 10;10(7):e0132291. doi: 10.1371/journal.pone.0132291. eCollection 2015.
9
Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy.
AIDS Res Hum Retroviruses. 2001 Sep 20;17(14):1357-63. doi: 10.1089/08892220152596614.
10
The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset.
Immunology. 2005 Jun;115(2):197-205. doi: 10.1111/j.1365-2567.2005.02153.x.
引用本文的文献
1
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression.
Clin Transl Immunology. 2024 Jan 29;13(2):e1486. doi: 10.1002/cti2.1486. eCollection 2024.
2
Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
Front Immunol. 2022 Apr 22;13:867167. doi: 10.3389/fimmu.2022.867167. eCollection 2022.
3
Differential skewing of donor-unrestricted and γδ T cell repertoires in tuberculosis-infected human lungs.
J Clin Invest. 2020 Jan 2;130(1):214-230. doi: 10.1172/JCI130711.
4
γδ T-cell responses during HIV infection and antiretroviral therapy.
Clin Transl Immunology. 2019 Jul 17;8(7):e01069. doi: 10.1002/cti2.1069. eCollection 2019.
5
Harnessing CD8 T Cells Under HIV Antiretroviral Therapy.
Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019.
6
Interleukin-18 activates Vγ9Vδ2 T cells from HIV-positive individuals: recovering the response to phosphoantigen.
Immunology. 2017 Aug;151(4):385-394. doi: 10.1111/imm.12735. Epub 2017 May 24.
7
Ageing and inflammation in patients with HIV infection.
Clin Exp Immunol. 2017 Jan;187(1):44-52. doi: 10.1111/cei.12814. Epub 2016 Aug 9.
8
Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count.
PLoS One. 2015 Jul 10;10(7):e0132291. doi: 10.1371/journal.pone.0132291. eCollection 2015.
9
γδ T Cells in HIV Disease: Past, Present, and Future.
Front Immunol. 2015 Jan 30;5:687. doi: 10.3389/fimmu.2014.00687. eCollection 2014.
10
Distortion of memory Vδ2 γδ T cells contributes to immune dysfunction in chronic HIV infection.
Cell Mol Immunol. 2015 Sep;12(5):604-14. doi: 10.1038/cmi.2014.77. Epub 2014 Sep 15.
本文引用的文献
1
Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells.
J Infect Dis. 2007 Jan 1;195(1):37-45. doi: 10.1086/509823. Epub 2006 Nov 20.
2
Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.
Cancer Immunol Immunother. 2007 Jun;56(6):819-29. doi: 10.1007/s00262-006-0235-6. Epub 2006 Nov 28.
3
HIV infection: first battle decides the war.
Trends Immunol. 2006 Jun;27(6):274-81. doi: 10.1016/j.it.2006.04.007. Epub 2006 May 6.
4
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells.
J Leukoc Biol. 2006 Apr;79(4):663-6. doi: 10.1189/jlb.1105640. Epub 2006 Feb 3.
5
Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma.
Expert Rev Anticancer Ther. 2005 Dec;5(6):973-86. doi: 10.1586/14737140.5.6.973.
6
NK cells in HIV infection: paradigm for protection or targets for ambush.
Nat Rev Immunol. 2005 Nov;5(11):835-43. doi: 10.1038/nri1711.
7
gammadelta T cells: a new frontier for immunotherapy?
Biol Blood Marrow Transplant. 2005 Mar;11(3):161-8. doi: 10.1016/j.bbmt.2004.11.015.
8
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.
J Exp Med. 2004 Oct 4;200(7):587-99.
9
The role of CD8+ T-cell response in HIV infection.
AIDS Rev. 2004 Apr-Jun;6(2):79-88.
10
Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.
J Infect Dis. 2004 Apr 15;189(8):1482-6. doi: 10.1086/382961. Epub 2004 Mar 30.
Zotero 插件